Dexamethasone pulse therapy: Evidence for no benefit in pemphigus

Jonkman, Marcel F.

doi:10.4103/0378-6323.77462

Indian J Dermatol Venereol Leprol

2011

DOI: 10.4103/0378-6323.77462

|View full text |Cite

Dexamethasone pulse therapy: Evidence for no benefit in pemphigus

Marcel F. Jonkman¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2015

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Efficacy and Safety of Dexamethasone Cyclophosphamide Pulse Therapy in the Treatment of Pemphigus - An Open Randomized Controlled Study

Gupta

2015

Apollo Medicine

View full text Add to dashboard Cite

Background: Various drugs used to treat pemphigus can cause remission, but none can provide permanent remission as relapses are common. With the introduction of DCP in pemphigus in 1984, patients started being in prolonged/permanent remission. This study was done to compare the efficacy of DCP to oral corticosteroids and cyclophosphamide in combination.Methods: Patients were allocated into two treatment groups. Group A received treatment with DCP pulse regimen while group B was treated with oral corticosteroids and cyclophosphamide lasting for 4 years.Results: 18 out of 20 patients in DCP group entered into remission, 1-29 months after complete stoppage of treatment. The two patients relapsed, one in phase III and another in phase IV of DCP. Both were reverted back to phase I and again treated with IV phase regimen of DCP. All the 20 patients in oral corticosteroids and cyclophosphamide group developed repeated relapses (4-6 times) during the study period. Conclusion:This study shows that DCP therapy can put pemphigus into prolonged/permanent remission as compared to corticosteroid-cyclophosphamide group where relapses are frequent. Lately, some dermatologists have questioned the efficacy of DCP in treating pemphigus. However, this could be due to usage of wrong combination of drugs or short study duration.

show abstract

Efficacy and Safety of Dexamethasone Cyclophosphamide Pulse Therapy in the Treatment of Pemphigus - An Open Randomized Controlled Study

Gupta

2015

Apollo Medicine

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Dexamethasone pulse therapy: Evidence for no benefit in pemphigus

Cited by 1 publication

References 7 publications

Efficacy and Safety of Dexamethasone Cyclophosphamide Pulse Therapy in the Treatment of Pemphigus - An Open Randomized Controlled Study

Efficacy and Safety of Dexamethasone Cyclophosphamide Pulse Therapy in the Treatment of Pemphigus - An Open Randomized Controlled Study

Contact Info

Product

Resources

About